204 related articles for article (PubMed ID: 28993509)
1. A Large-Scale RNAi Screen Identifies SGK1 as a Key Survival Kinase for GBM Stem Cells.
Kulkarni S; Goel-Bhattacharya S; Sengupta S; Cochran BH
Mol Cancer Res; 2018 Jan; 16(1):103-114. PubMed ID: 28993509
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia.
Hofstetter CP; Burkhardt JK; Shin BJ; Gürsel DB; Mubita L; Gorrepati R; Brennan C; Holland EC; Boockvar JA
PLoS One; 2012; 7(1):e30059. PubMed ID: 22253878
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
[TBL] [Abstract][Full Text] [Related]
5. Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia.
Matschke J; Wiebeck E; Hurst S; Rudner J; Jendrossek V
Radiat Oncol; 2016 Jun; 11():75. PubMed ID: 27251632
[TBL] [Abstract][Full Text] [Related]
6. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
7. The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells.
Catalogna G; Talarico C; Dattilo V; Gangemi V; Calabria F; D'Antona L; Schenone S; Musumeci F; Bianco C; Perrotti N; Amato R; Cascini GL
Cell Physiol Biochem; 2017; 43(1):108-119. PubMed ID: 28848088
[TBL] [Abstract][Full Text] [Related]
8. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
9. Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Poungvarin N; Sathornsumetee S; Issaragrisil S
Tumour Biol; 2016 Nov; 37(11):14949-14960. PubMed ID: 27651158
[TBL] [Abstract][Full Text] [Related]
10. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
Bell JB; Eckerdt FD; Alley K; Magnusson LP; Hussain H; Bi Y; Arslan AD; Clymer J; Alvarez AA; Goldman S; Cheng SY; Nakano I; Horbinski C; Davuluri RV; James CD; Platanias LC
Mol Cancer Res; 2016 Oct; 14(10):984-993. PubMed ID: 27364770
[TBL] [Abstract][Full Text] [Related]
11. Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells.
Daniele S; Sestito S; Pietrobono D; Giacomelli C; Chiellini G; Di Maio D; Marinelli L; Novellino E; Martini C; Rapposelli S
ACS Chem Neurosci; 2017 Jan; 8(1):100-114. PubMed ID: 27797168
[TBL] [Abstract][Full Text] [Related]
12. In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.
Sa JK; Yoon Y; Kim M; Kim Y; Cho HJ; Lee JK; Kim GS; Han S; Kim WJ; Shin YJ; Joo KM; Paddison PJ; Ishitani T; Lee J; Nam DH
Oncotarget; 2015 Aug; 6(24):20145-59. PubMed ID: 26023737
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.
Tafani M; Di Vito M; Frati A; Pellegrini L; De Santis E; Sette G; Eramo A; Sale P; Mari E; Santoro A; Raco A; Salvati M; De Maria R; Russo MA
J Neuroinflammation; 2011 Apr; 8():32. PubMed ID: 21489226
[TBL] [Abstract][Full Text] [Related]
14. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
15. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
16. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
Reddy RG; Bhat UA; Chakravarty S; Kumar A
Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
[TBL] [Abstract][Full Text] [Related]
17. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
19. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
[TBL] [Abstract][Full Text] [Related]
20. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]